Within a substantial and carefully characterized population of HCC patients undergoing TARE, our study revealed a remarkable correlation between pre-TARE interleukin-8 (IL-8) levels and key indicators of liver function and necro-inflammation. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.